Environmental Burkholderia cepacia complex isolates in human infections

被引：103

作者：

Baldwin, Adam

Mahenthiralingam, Eshwar

Drevinek, Pavel

Vandamme, Peter

Govan, John R.

Waine, David J.

LiPuma, John J.

Chiarini, Luigi

Dalmastri, Claudia

Henry, Deborah A.

Speert, David P.

Honeybourne, David

Maiden, Martin C. J.

Dowson, Chris G. ^{[1
]}

机构：

[1] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England

[2] Cardiff Univ, Cardiff, Wales

[3] Univ Ghent, B-9000 Ghent, Belgium

[4] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland

[5] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA

[6] Ente Nuove Tecnol Energia & Ambiente Casaccia, Rome, Italy

[7] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada

[8] Birmingham Heartlands Hosp, Birmingham, W Midlands, England

[9] Univ Oxford, Oxford, England

来源：

EMERGING INFECTIOUS DISEASES | 2007年 / 13卷 / 03期

基金：

英国惠康基金;

关键词：

D O I：

10.3201/eid1303.060403

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Members of the Burkholderia cepacia complex (Bcc), found in many environments, are associated with clinical infections. Examining diverse species and strains from different environments with multilocus sequence typing, we identified > 20% of 381 clinical isolates as indistinguishable from those in the environment. This finding links the natural environment with the emergence of many Rcc infections.

引用

收藏

页码：458 / 461

页数：4

相关论文

共 15 条

[1] Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex [J].

Baldwin, A ;

Mahenthiralingam, E ;

Thickett, KM ;

Honeybourne, D ;

Maiden, MCJ ;

Govan, JR ;

Speert, DP ;

LiPuma, JJ ;

Vandamme, P ;

Dowson, CG .

JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) :4665-4673

[2] Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe [J].

Coenye, T ;

Spilker, T ;

Van Schoor, A ;

LiPuma, JJ ;

Vandamme, P .

THORAX, 2004, 59 (11) :952-954

[3] Updated version of the Burkholderia cepacia complex experimental strain panel [J].

Coenye, T ;

Vandamme, P ;

LiPuma, JJ ;

Govan, JRW ;

Mahenthiralingam, E .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (06) :2797-2798

[4] Taxonomy and identification of the Burkholderia cepacia complex [J].

Coenye, T ;

Vandamme, P ;

Govan, JRW ;

Lipuma, JJ .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (10) :3427-3436

[5] Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center:: a 7-year study [J].

Cunha, MV ;

Leitao, JH ;

Mahenthiralingam, E ;

Vandamme, P ;

Lito, L ;

Barreto, C ;

Salgado, MJ ;

Sá-Correia, I .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (09) :4113-4120

[6] EVIDENCE FOR TRANSMISSION OF PSEUDOMONAS-CEPACIA BY SOCIAL CONTACT IN CYSTIC-FIBROSIS [J].

GOVAN, JRW ;

BROWN, PH ;

MADDISON, J ;

DOHERTY, CJ ;

NELSON, JW ;

DODD, M ;

GREENING, AP ;

WEBB, AK .

LANCET, 1993, 342 (8862) :15-19

[7]

Govan JRW, 2000, ASM NEWS, V66, P124

[8] Agricultural use of Burkholderia (Pseudomonas) cepacia: A threat to human health? [J].

Holmes, A ;

Govan, J ;

Goldstein, R .

EMERGING INFECTIOUS DISEASES, 1998, 4 (02) :221-227

[9] Home-use nebulizers: A potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis [J].

Hutchinson, GR ;

Parker, S ;

Pryor, JA ;

DuncanSkingle, F ;

Hoffman, PN ;

Hodson, ME ;

Kaufmann, ME ;

Pitt, TL .

JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) :584-587

[10] An epidemic Burkholderia cepacia complex strain identified in soil [J].

LiPuma, JJ ;

Spilker, T ;

Coenye, T ;

Gonzalez, CF .

LANCET, 2002, 359 (9322) :2002-2003